{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:46:32Z","timestamp":1791103592690,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2228,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1038\/mt.2010.119","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T14:13:19Z","timestamp":1277215999000},"page":"1592-1598","source":"Crossref","is-referenced-by-count":22,"title":["Neonatal Gene Therapy of Glycogen Storage Disease Type Ia Using a Feline Immunodeficiency Virus\u2013based Vector"],"prefix":"10.1016","volume":"18","author":[{"given":"Albert","family":"Grinshpun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reba","family":"Condiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"N Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Zeig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Simerzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jiunn","family":"Pann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilla","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithan","family":"Galun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.119_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1566524013364112","article-title":"The molecular basis of type 1 glycogen storage diseases","volume":"1","author":"Chou","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.1038\/mt.2010.119_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/156652307780363152","article-title":"Gene therapy for type I glycogen storage diseases","volume":"7","author":"Chou","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2010.119_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2010.119_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1354\/vp.38-1-83","article-title":"Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia)","volume":"38","author":"Kishnani","year":"2001","journal-title":"Vet Pathol"},{"key":"10.1038\/mt.2010.119_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib6","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/BF02679996","article-title":"Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a","volume":"161","author":"Chou","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2010.119_bib7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/labinvest.2009.64","article-title":"A detailed characterization of the adult mouse model of glycogen storage disease Ia","volume":"89","author":"Salganik","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/mt.2010.119_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1074\/jbc.275.2.828","article-title":"Correction of glycogen storage disease type 1a in a mouse model by gene therapy","volume":"275","author":"Zingone","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.119_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.mt.6300188","article-title":"Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia","volume":"15","author":"Koeberl","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.119_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/mt.2008.15","article-title":"AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia","volume":"16","author":"Koeberl","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.119_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2010.119_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/gt.2008.55","article-title":"Adeno-associated virus integration: virus versus vector","volume":"15","author":"Smith","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2010.119_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1521-2254(200005\/06)2:3<186::AID-JGM100>3.0.CO;2-6","article-title":"The application of a lentiviral vector for gene transfer in fetal human hepatocytes","volume":"2","author":"Zahler","year":"2000","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2010.119_bib16","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.00227-08","article-title":"Lentivirus vector can be readministered to nasal epithelia without blocking immune responses","volume":"82","author":"Sinn","year":"2008","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.119_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1038\/mt.2010.119_bib18","first-page":"1391","article-title":"ProSavin a gene therapy approach for Parkinson's disease","volume":"20","author":"Jarraya","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.119_bib19","first-page":"1369","article-title":"Conversion to transfusion independence with partial clonal dominance after lentiviral gene therapy for severe human beta-thalessemia","volume":"20","author":"Leboulch","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.119_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vetimm.2008.01.009","article-title":"Human gene therapy vectors derived from feline lentiviruses","volume":"123","author":"Barraza","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1038\/mt.2010.119_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1021078714105","article-title":"FIV vector systems","volume":"26","author":"Sauter","year":"2001","journal-title":"Somat Cell Mol Genet"},{"key":"10.1038\/mt.2010.119_bib22","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.119_bib23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.gt.3302979","article-title":"The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors","volume":"14","author":"Higashimoto","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib24","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.119_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.mt.6300152","article-title":"Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors","volume":"15","author":"Schambach","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.119_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gt.3302417","article-title":"Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)","volume":"12","author":"Kingsman","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2004.06.044","article-title":"Prolonged liver-specific transgene expression by a non-primate lentiviral vector","volume":"320","author":"Condiotti","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2010.119_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jhep.2007.11.014","article-title":"Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia","volume":"48","author":"Kim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2010.119_bib29","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1016\/j.febslet.2007.07.013","article-title":"Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type Ia","volume":"581","author":"Kim","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1038\/mt.2010.119_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg1829","article-title":"Genetic medicines: treatment strategies for hereditary disorders","volume":"7","author":"O'Connor","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2010.119_bib31","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2010.119_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156652307782151434","article-title":"Immunology of neonatal gene transfer","volume":"7","author":"Ponder","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2010.119_bib33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1538-7933.2004.00671.x","article-title":"Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A","volume":"2","author":"Madoiwa","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1038\/mt.2010.119_bib34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/gt.2009.87","article-title":"Progress and prospects: prospects of repeated pulmonary administration of viral vectors","volume":"16","author":"Sinn","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1089\/hum.2006.17.1112","article-title":"Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy","volume":"17","author":"Di Domenico","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.119_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ymthe.2005.07.358","article-title":"Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice","volume":"12","author":"Themis","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.119_bib38","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.gt.3301587","article-title":"A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors","volume":"8","author":"Zhang","year":"2001","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.119_bib39","first-page":"191","article-title":"The estimation of glycogen with the anthrone reagent","volume":"25","author":"Seifter","year":"1950","journal-title":"Arch Biochem"},{"key":"10.1038\/mt.2010.119_bib40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1089\/hum.2006.127","article-title":"Enhanced gene expression conferred by stepwise modification of a nonprimate lentiviral vector","volume":"18","author":"Sinn","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.119_bib41","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1083\/jcb.42.2.444","article-title":"I. Quantitative determination of the amount of DNA per nucleus by interference microscopy","volume":"42","author":"Bibbiani","year":"1969","journal-title":"J Cell Biol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616308346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616308346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T01:01:54Z","timestamp":1591405314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616308346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1525001616308346"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.119","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}